Pharmaceutical manufacturers can sue competitors for market exclusivity for an orphan drug. This was the outcome of a decision by Munich Regional Court in the dispute between Alexion and Amgen over
designed to protect drug-related patents. For instance, it provides a legal basis for the early settlement of disputes over pharmaceutical patents, allowing patent holders and those seeking market
total 1 pages, 2 items